| Title |
Levetiracetam add‐on for drug‐resistant focal epilepsy: an updated Cochrane Review
|
|---|---|
| Published in |
Cochrane database of systematic reviews, September 2012
|
| DOI | 10.1002/14651858.cd001901.pub2 |
| Pubmed ID | |
| Authors |
Gashirai K Mbizvo, Pete Dixon, Jane L Hutton, Anthony G Marson |
| Abstract |
Epilepsy is an important neurological condition and drug resistance in epilepsy is particularly common in individuals with focal seizures. In this review, we summarise the current evidence regarding a new antiepileptic drug, levetiracetam, when used as add-on treatment for controlling drug-resistant focal epilepsy. This is an update to a Cochrane Review that was originally published in 2001. |
Mendeley readers
The data shown below were compiled from readership statistics for 157 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| Italy | 2 | 1% |
| United Kingdom | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 151 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 36 | 23% |
| Researcher | 22 | 14% |
| Student > Postgraduate | 14 | 9% |
| Student > Ph. D. Student | 13 | 8% |
| Other | 12 | 8% |
| Other | 30 | 19% |
| Unknown | 30 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 39% |
| Nursing and Health Professions | 13 | 8% |
| Psychology | 12 | 8% |
| Neuroscience | 9 | 6% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 18 | 11% |
| Unknown | 38 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2020.
All research outputs
#4,893,216
of 25,604,262 outputs
Outputs from Cochrane database of systematic reviews
#7,258
of 13,148 outputs
Outputs of similar age
#34,347
of 187,728 outputs
Outputs of similar age from Cochrane database of systematic reviews
#128
of 231 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,148 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.